Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | BRD4 | O60885 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.46 |
| ▸ | LTA4H | P09960 | 3/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.43 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4896582 | 0.92 | CES2 (0.47) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL4894161 | 0.89 | NPC1 (0.53) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL1793418 | 0.85 | KDM4E (0.47) | MAPTKMT2A | |
| SCHEMBL1796284 | 0.85 | KMT2A (0.48) | KMT2ABRD4CYP2D6TSHRCYP1A2 | |
| SCHEMBL4899699 | 0.84 | NQO1 (0.52) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL11354421 | 0.84 | THRA (0.54) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL11357497 | 0.84 | THRA (0.54) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL8143543 | 0.84 | THRA (0.54) | MEN1NPC1ALDH1A1GAAMAPT | |
| SCHEMBL1793417 | 0.83 | SLC6A4 (0.46) | KMT2ABRD4CYP2D6CYP1A2CYP2C19 | |
| SCHEMBL1798445 | 0.83 | MAPT (0.50) | MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-5169829-A | — | — | None | — | — | JP | disclosed |
| JP-5169830-A | — | — | None | — | — | JP | disclosed |
| US-8084559-B2 | Ethylene-vinylcyclohexane copolymers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | SUMITOMO CHEMICAL COMPANY, LIMTIED (JP) | 2008-07-03 | — | — | US | disclosed |
| JP-H05169829-A | THERMAL RECORDING MATERIAL | KANZAKI PAPER MFG CO LTD | 1993-07-09 | — | — | JP | disclosed |
| JP-H05169830-A | THERMAL RECORDING MATERIAL | KANZAKI PAPER MFG CO LTD | 1993-07-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161514-A1 | Transition Metal Complex, Process For Producing Said Transition Metal Complex, Substituent-Carrying Fluorene Compound, Process For Producing Said Fluorene Compound, Catalyst Component For Olefin Polymerization, Catalyst For Olefin Polymerization, and Process For Producing Olefin Polymer | AOC2, ACSL1, ACSL3 | MEN1 2068/4885NPC1 1751/4885ALDH1A1 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.